top of page
A Danish biotech aiming to develop more efficacious & safer drugs for the treatment of atrial fibrillation
Acesion Pharma ApS is a Danish biotech company founded in 2011 as a spin out from the company Neurosearch and University of Copenhagen. By inhibiting the SK ion channel, we aim to develop first-in-class drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
bottom of page